Hostname: page-component-77c89778f8-n9wrp Total loading time: 0 Render date: 2024-07-20T05:04:43.782Z Has data issue: false hasContentIssue false

Correlation of functioning level with level of anxiety, depression and hopelessness in patients under the treatment with psychopharmacotherapy

Published online by Cambridge University Press:  16 April 2020

J. Petkovic
Affiliation:
Psychiatric Clinic, UKC, Tuzla, Bosnia and Herzegovina
E. Tupkovic
Affiliation:
Psychiatric Clinic, UKC, Tuzla, Bosnia and Herzegovina

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In our prospective study we analyzed 30 of patients (20 females) with anxious depressive disorders, mean age 37,6 ± 10,8 (20-57) years, treated with antidepressive agents. For 18 months there have been used Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Back Hopelessness Scale (BHS) and GAF on the beginning, at the end of treatment (after 12 months), and 6 months after treatment. At the beginning of treatment next mean values were observed: BDI 42,5 ± 13,1, BAI 32,6 ± 14,7, BHS 9,2± 6,9, and GAF 51,9 ± 9,1.

GAF shoved negative correlation in comparison with BAI (-0,60), BDI (-0,66), and BHS (-0,54). After one year of medication mean value of improvements were: for BDI 31,7 ± 10,8, for BAI 24,1 ± 13,3, for BHS 7,5 ± 5,8, and for GAF 13,2 ± 5,4. GAF still highly correlated with BDI (-69), with BAI (-0.56) and with BSB (-0.44). Six months after all parameters were significantly worsen: BDI 5,1 ± 2,3, BAI 4,2 ± 2,8, BHS 1,5 ± 1,8, and GAF -5,0 ± 1,4. GAF still correlated with BDI (-0,41), BAI (-0,39), but correlation rate with BHS was very low (-0,23).

Conclusion:

Due to negative correlation rates with level of depression, anxiety and hopelessness it is possible to apply GAF like measure of assessment of patient's depression and anxiety, and useful follow up tool of patients treatment with psychopharmacotherapy.

Type
Poster Session 2: Depressive Disorders
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.